drugset
Drugs / Quadrivalent meningococcal conjugate vaccine
last change Mar 2013 re-read 3 minutes ago

Quadrivalent meningococcal conjugate vaccine

Vaccine

Developed for
bacterial meningitis
Investigated by
International Maternal Pediatric Adolescent AIDS Clinical Trials Group · National Institute of Allergy and Infectious Diseases (NIAID)

Trials 1

today NCT00459316 · Ph 1/2
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT00459316 Jun 2007 → Mar 2013 HIV infectious disease, bacterial meningitis National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Quadrivalent meningococcal conjugate vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00459316 ↗
Modality Vaccine “The quadrivalent meningococcal conjugate vaccine (MCV4) is a vaccine” NCT00459316 ↗
Route Intramuscular “was given by injection intramuscularly” NCT00459316 ↗